Home LiteratureArticle Details
PMID: 7637145 Published · ppublish English Journal Article Multicenter Study Research Support, Non-U.S. Gov't

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

JAMA ·Vol. 274 ·No. 8 ·1995-00-00 ·Pages 639-44

Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M

Abstract

To determine the prevalence of intensive care unit (ICU)-acquired infections and the risk factors for these infections, identify the predominant infecting organisms, and evaluate the relationship between ICU-acquired infection and mortality. A 1-day point-prevalence study. Intensive care units in 17 countries in Western Europe, excluding coronary care units and pediatric and special care infant units. All patients (> 10 years of age) occupying an ICU bed over a 24-hour period. A total of 1417 ICUs provided 10 038 patient case reports. Rates of ICU-acquired infection, prescription of antimicrobials, resistance patterns of microbiological isolates, and potential risk factors for ICU-acquired infection and death. A total of 4501 patients (44.8%) were infected, and 2064 (20.6%) had ICU-acquired infection. Pneumonia (46.9%), lower respiratory tract infection (17.8%), urinary tract infection (17.6%), and bloodstream infection (12%) were the most frequent types of ICU infection reported. Most frequently reported micro-organisms were Enterobacteriaceae (34.4%), Staphylococcus aureus (30.1%;[60% resistant to methicillin], Pseudomonas aeruginosa (28.7%), coagulase-negative staphylococci (19.1%), and fungi (17.1%). Seven risk factors for ICU-acquired infection were identified: increasing length of ICU stay (> 48 hours), mechanical ventilation, diagnosis of trauma, central venous, pulmonary artery, and urinary catheterization, and stress ulcer prophylaxis. ICU-acquired pneumonia (odds ratio [OR], 1.91; 95% confidence interval[Cl], 1.6 to 2.29), clinical sepsis (OR, 3.50; 95% Cl, 1.71 to 7.18), and bloodstream infection (OR, 1.73; 95% Cl, 1.25 to 2.41) increased the risk of ICU death. ICU-acquired infection is common and often associated with microbiological isolates of resistant organisms. The potential effects on outcome emphasize the importance of specific measures for infection control in critically ill patients.

MeSH Terms
APACHE Anti-Bacterial Agents/therapeutic use Bacterial Infections/drug therapy,epidemiology,mortality Cross Infection/drug therapy,epidemiology,microbiology,mortality Drug Resistance, Microbial Drug Utilization Europe/epidemiology Hospital Mortality Humans Intensive Care Units/statistics & numerical data Logistic Models Mycoses/drug therapy,epidemiology,mortality Prevalence Risk Factors Survival Analysis
Chemicals
Anti-Bacterial Agents
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Vincent J L
Department of Intensive Care, Erasme University Hospital, Brussels, Belgium.
Bihari D J
Suter P M
Bruining H A
White J
Nicolas-Chanoin M H
Wolff M
Spencer R C
Hemmer M
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
0098-7484
Published
1995-00-00
Pages
639-44
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]